BNP Sees US Mega IPOs Fueling Appetite for Tech Deals in Europe

A $3.6 trillion pipeline of potential US tech IPOs, including SpaceX, OpenAI and Anthropic, is expected to boost investor appetite for tech stock sales in Europe as well. BNP Paribas says the scale and excitement around these offerings could create positive ripple effects across global equity capital markets, especially for European tech listings.

Analysis

The signal here is not just “more IPOs,” but a re-pricing of exit optionality across private tech. When headline names command massive checks, late-stage investors become more willing to mark up adjacent assets, and banks get a larger feeder pool for secondary/primary issuance in Europe; that tends to compress IPO discount rates for the whole cohort. The first-order beneficiaries are European growth platforms with clean narratives and revenue durability, while the hidden losers are private-market buyers who need to underwrite to lower liquidity assumptions and longer hold periods.

The second-order effect is that this widens the gap between AI-adjacent assets with credible monetization and the rest of tech. If public-market appetite stays strong for 6-12 months, expect stronger demand for infrastructure, semis, cloud-enablement, and cybersecurity names that can be packaged as “picks-and-shovels” rather than speculative software. Conversely, software companies with stretched private valuations and weak retention metrics will face a tougher path: a hot IPO window can be a forcing function for disclosure, and that often reveals which growth stories were mostly narrative-driven.

The main risk is timing. Equity issuance windows can shut quickly if rates back up, a single marquee IPO disappoints, or broad AI enthusiasm rotates into profitability discipline; that would hit European deal flow with a lag of 1-2 quarters because bankers and issuers usually react after the US tape has already turned. Another risk is that too many mega-listings absorb risk capital, leaving less marginal demand for smaller European names even if sentiment is constructive on the sector overall.

The contrarian view is that this may be more of a liquidity redistribution than a durable expansion in risk appetite. Mega IPOs often crowd out mid-cap issuance and create a “winner-take-most” market where investors concentrate in a handful of names and demand a steep discount for everything else. If that happens, the right trade is not broad long tech exposure, but selective long quality versus short weak balance-sheet or unprofitable software that will struggle to clear valuation hurdles once the spotlight shifts.

Key Decisions for Investors

• Go long a basket of high-quality European tech/platform names on any primary-market weakness over the next 1-3 months; best risk/reward is in businesses with recurring revenue and net cash, where IPO-window reopening can add 10-20% multiple support.
• Pair trade: long profitable AI infrastructure beneficiaries (SMCI, NVDA, ASML) vs short unprofitable software/elevated-duration names; target 3-6 month horizon if IPO enthusiasm broadens into hardware and picks-and-shovels demand.
• Buy optionality on European financials with ECM leverage via select banks/markets franchises for the next 2 quarters; upside is convex if issuance volumes accelerate, while downside is limited by diversified earnings.
• Short or underweight late-stage private software proxies if they come public in the next 6-12 months without clear margin traction; the risk/reward favors fading any first-day pops when supply of paper is large and lock-up overhang is imminent.